VXRT

Vaxart Stock Has Built-In Value Well Beyond Its Covid Pill

Vaxart: World's First Oral COVID Vaccine In Development

Vaxart Is Gaining Relevance, But Its Future Is Still Uncertain

Why Shares of Vaxart Jumped 31.2% in the First Half of 2021

3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street

Don't Count on a Covid-19 Boost for Vaxart

New Developments Have Made Vaxart Stock So Much More Attractive